Australia is one of the global epicentres in health and wellbeing, with one of the most proactive health-conscious consumer bases in the Asia-Pacific region. The country’s supplement market is booming, and growth is only accelerating.
According to Grand View Research, the Australian nutritional supplements market reached USD 13.74 billion in 2023 and shows no signs of slowing, with a robust compound annual growth rate (CAGR) of 5.6% projected through to 2030.
But it’s not just vitamins and protein powders fuelling the surge – like many markets around the globe, gut health is in the spotlight, and prebiotics are primed for significant growth. An analysis published in Scientific Reports using Google Trends found that Australia leads the world in online searches for “gut microbiome”, outpacing every other country globally.
Prebiotics: The fastest mover in the supplement aisle
Valued at USD 228 million in 2023, Australia’s prebiotics market is expected to more than triple to USD 708 million by 2030 – an impressive CAGR of 17.6%. Consumers are increasingly recognising the gut microbiome’s role in overall health and wellbeing, not just for digestion but for immunity, cognition, energy and more.
Showing the versatility in action, prebiotics are moving beyond supplement jars, they’re breaking into mainstream food and beverage categories – think functional drinks, snack bars, and even infant formula. For formulators based in Australia and New Zealand, the signal is loud and clear: microbiome-focused products aren’t a niche category, they have entered the mainstream.
A perfect storm for innovation
Australia’s demographic trends are primed for gut health innovation. An ageing population is driving interest in proactive wellness strategies, especially those grounded in science. At the same time, there’s a growing consumer shift toward natural, functional, and clinically backed ingredients. Combine that with high regulatory standards, and the opportunity for credible, differentiated products becomes even clearer. This is where prebiotics like Bimuno® GOS enter the picture.
Bimuno GOS can now be included in Australia’s Therapeutic Goods Administration (TGA) listed products – a milestone that opens new doors for brands looking to formulate with a prebiotic ingredient supported by both scientific rigour and regulatory credibility. With this recognition, products containing Bimuno GOS can carry authorised health claims under the TGA framework, making it easier for formulators to build trust with consumers right from the pack.
This adds to an already strong standing within the FSANZ (Food Standards Australia and New Zealand) system, where 29 self-substantiated food-health relationship claims are approved – Covering benefits ranging from gut and immune support, to targeted benefits for elite athletes.
This dual regulatory footprint sets Bimuno GOS apart in the prebiotic ingredient category, and gives product developers a faster, more confident route to market.
Differentiation built in
Formulators are under pressure to deliver products that meet the needs of health consumers and put scientific validation at the heart. Bimuno GOS answers that call with:
Whether you’re building supplements, sports nutrition lines, or functional foods, Bimuno GOS gives you science, stability, and shelf appeal – all in one functional ingredient.
The Australian supplement market is growing – and fast. With consumers now expecting visible, credible benefits, the pressure is on for brands to deliver. Prebiotics, and Bimuno GOS in particular, offer a science-first solution that’s ready to meet that demand.
Get in touch with our team today to explore how Bimuno GOS can support your next product in Australia or New Zealand – and access the full list of authorised health claims available for your category.
